| Heading: |
Medicines and Healthcare products Regulatory Agency: Finance |
| Question ID: |
1750412 |
| UIN: |
20468 |
| House: |
Commons |
| Date tabled: |
2024-12-16 |
| Asking Member ID: |
5158 |
| Asking Member display name: |
Rupert Lowe
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Rupert Lowe
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if will make an assessment of the potential merits of conducting a review into the funding of the Medicines and Healthcare products Regulatory Agency. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-31 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
There is currently no planned review of the funding of the Medicines and Healthcare products Regulatory Agency (MHRA).The MHRA is funded predominately by charging fees to industry, for the services it delivers, with additional funding being provided by th... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |